Joinn Laboratories(China)Co.,Ltd.
603127
Rang in Aktien
#3812
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Aktienkurs
$6.82
Marktkapitalisierung
$4.30B
Veränderung (1 Tag)
-6.30%
Veränderung (1 Jahr)
48.79%
Land
CN
Handel Joinn Laboratories(China)Co.,Ltd. (603127)
Kategorie
Healthcare
P/S-Verhältnis für Joinn Laboratories(China)Co.,Ltd. (603127)
P/S-Verhältnis zum October 2026 TTM: 16.96
Laut den neuesten Finanzberichten und dem Aktienkurs von Joinn Laboratories(China)Co.,Ltd. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 16.96. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 6.10.
P/S-Verlauf für Joinn Laboratories(China)Co.,Ltd. von 2012 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 16.96 | 7.83% |
| 2025 | 15.73 | 157.67% |
| 2024 | 6.10 | -15.66% |
| 2023 | 7.24 | -47.54% |
| 2022 | 13.80 | -50.84% |
| 2021 | 28.06 | 29.16% |
| 2020 | 21.73 | 49.50% |
| 2019 | 14.53 | 9.31% |
| 2018 | 13.30 | 3.24% |
| 2017 | 12.88 | 181.31% |
| 2016 | 4.58 | -14.49% |
| 2015 | 5.35 | -10.22% |
| 2014 | 5.96 | -23.01% |
| 2013 | 7.75 | -30.15% |
| 2012 | 11.09 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| 5.29 | -68.79% |
US
|
|
| 6.43 | -62.11% |
US
|
|
| 21.32 | 25.68% |
US
|
|
| 6.53 | -61.51% |
CN
|
|
| 6.80 | -59.91% |
US
|
